Amber Tong for Endpoints News
Chalk up a big win for Bain as SpringWorks IPO tops out at $162M
SpringWorks Therapeutics’ IPO has delivered a $162 million bounty — upsized from its original $115 million pitch — in a resounding endorsement for Bain’s Big Pharma spinout model for biotech creation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.